Coley Clark - 13 Feb 2025 Form 4 Insider Report for XBP Europe Holdings, Inc. (XBP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Feb 2025, 20:01:13 UTC
Prior SEC filing
17 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dejan Avramovic, Attorney-in-Fact for Coley Clark

Key filing fact

Coley Clark filed Form 4 for XBP Europe Holdings, Inc. (XBP) on 18 Feb 2025.

Key facts

  • This page summarizes Coley Clark's Form 4 filing for XBP Europe Holdings, Inc. (XBP).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Feb 2025, 20:01.

Change

  • Previous filing in this sequence was filed on 17 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XBP transaction

Common Stock, par value $0.0001 per share

Award

Transaction value
$0
Shares
+119,436
Change %
+183%
Price
$0.000000
Shares after
184,857
Date
13 Feb 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents Restricted Stock Units ("RSUs") issued to the Reporting Person under the XBP Europe Holdings, Inc. 2024 Stock Incentive Plan (the "Plan"). The RSUs granted under the Plan will vest in full on the first anniversary of the grant date.

SEC remarks

EXHIBIT 24 - Power of Attorney for Coley Clark

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .